当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析 - 现金流量表

天坛生物

(600161)

  

流通市值:240.65亿  总市值:240.65亿
流通股本:19.77亿   总股本:19.77亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,412,081,763.9991,221,205.84,734,373,938.473,075,023,127.55
  收到其他与经营活动有关的现金46,767,758.636,105,899.8981,028,757.383,623,172.21
  经营活动现金流入小计2,458,849,522.51,027,327,105.694,815,402,695.773,158,646,299.76
  购买商品、接受劳务支付的现金1,130,899,395.52543,382,939.132,267,585,618.381,611,489,389.79
  支付给职工以及为职工支付的现金472,580,353.32281,149,427.581,212,164,096.4669,693,580.99
  支付的各项税费469,611,704.68174,446,993.57767,125,365.15586,001,241.1
  支付其他与经营活动有关的现金96,401,553.843,855,941.44229,780,957.21174,567,059.81
  经营活动现金流出小计2,169,493,007.321,042,835,301.724,476,656,037.143,041,751,271.69
  经营活动产生的现金流量净额289,356,515.18-15,508,196.03338,746,658.63116,895,028.07
二、投资活动产生的现金流量:
  收回投资收到的现金14,150,365.653,772,865.94--
  取得投资收益收到的现金26,542,489.8326,542,489.8337,196,956.9637,100,956.96
  处置固定资产、无形资产和其他长期资产收回的现金净额14,67013,470339,337.03138,228.3
  处置子公司及其他营业单位收到的现金净额5,134,763.935,134,763.93--
  收到的其他与投资活动有关的现金506,000,000506,000,000709,000,000700,000,000
  投资活动现金流入小计551,842,289.41541,463,589.7746,536,293.99737,239,185.26
  购建固定资产、无形资产和其他长期资产支付的现金341,623,365.7187,146,547.77605,531,434.31450,530,338.98
  支付其他与投资活动有关的现金800,000,000800,000,00016,650,000-
  投资活动现金流出小计1,141,623,365.7987,146,547.77622,181,434.31450,530,338.98
  投资活动产生的现金流量净额-589,781,076.29-445,682,958.07124,354,859.68286,708,846.28
三、筹资活动产生的现金流量:
  取得借款收到的现金232,602,565.1286,953,347.1286,925,081.38252,966,301.42
  筹资活动现金流入小计232,602,565.1286,953,347.1286,925,081.38252,966,301.42
  分配股利、利润或偿付利息支付的现金25,990,000-706,612,364.61706,402,398.36
  其中:子公司支付给少数股东的股利、利润25,990,000-212,269,503.11212,269,503.11
  支付其他与筹资活动有关的现金7,825,191.381,101,139.6722,708,405.5718,726,597.1
  筹资活动现金流出小计33,815,191.381,101,139.67729,320,770.18725,128,995.46
  筹资活动产生的现金流量净额198,787,373.7485,852,207.43-442,395,688.8-472,162,694.04
四、汇率变动对现金及现金等价物的影响-29,715.9-14,958.93-28,934.14-9,499.67
五、现金及现金等价物净增加额-101,666,903.27-375,353,905.620,676,895.37-68,568,319.36
  加:期初现金及现金等价物余额1,443,597,800.411,443,597,800.411,422,920,905.041,422,920,905.04
  期末现金及现金等价物余额1,341,930,897.141,068,243,894.811,443,597,800.411,354,352,585.68
补充资料:
  净利润414,563,879.92-1,489,882,179.7-
  资产减值准备5,684,810.93-19,110,612.28-
  固定资产和投资性房地产折旧177,033,617.54-348,834,129.26-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧177,033,617.54-348,834,129.26-
  无形资产摊销40,183,920.41-76,618,593.93-
  长期待摊费用摊销15,958,703.93-32,280,975.62-
  处置固定资产、无形资产和其他长期资产的损失-21,397.95--104,452.59-
  固定资产报废损失-7,384.03-2,875,975.18-
  财务费用3,707,352.78-7,364,956.02-
  投资损失-9,252,615.18--29,398,010.78-
  递延所得税-9,829,950.91--12,871,040.86-
  其中:递延所得税资产减少-3,665,929.94--14,651,807.57-
    递延所得税负债增加-6,164,020.97-1,780,766.71-
  存货的减少-121,726,840.21--172,036,268.91-
  经营性应收项目的减少-387,229,377.76--1,375,668,968.71-
  经营性应付项目的增加134,208,594.59--113,339,500.64-
  现金的期末余额1,341,930,897.14-1,443,597,800.41-
  减:现金的期初余额1,443,597,800.41-1,422,920,905.04-
  现金及现金等价物的净增加额-101,666,903.27-20,676,895.37-
公告日期2026-08-292026-04-302026-03-282025-10-25
审计意见(境内)标准无保留意见
TOP↑